Health Trials

Tricuspid Atresia

2

Review clinical trials related to Tricuspid Atresia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts

A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connection.

Participants needed: 24
Trial details
Phase: Phase 2Biological sex: AllType: InterventionalSponsor: Nationwide Children's HospitalUpdated: Jun 27, 2025Locations: 1
Eligibility criteria

Patients will be eligible for inclusion in the study if they meet all of the fol... [+2]

Patients will be excluded from participation in the study if they meet any of th... [+11]

Read more
Status: Recruiting

NIRS in Congenital Heart Defects - Correlation With Echocardiography

Neonatal patients with congenital heart defects (CHD) have changing physiology in the context of transitional period. Patients with CHD are at risk of low perfusion status or abnormal pulmonary blood flow. Near infrared spectroscopy has been used in neonatal intensive care units (NICU) to measure end-organ perfusion. The investigator plan on monitoring newborns with CHD admitted to the NICU with NIRS and echocardiography during the first week of life and correlate measures of perfusion from Dopplers to cerebral and renal NIRS.

Participants needed: 100
Trial details
Age: 0-7Biological sex: AllType: ObservationalSponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreUpdated: Jun 17, 2025Locations: 1
Eligibility criteria

Not listed

Read more